Cytek Biosciences, Inc. (CTKB) Stock

Cytek Biosciences, Inc. (CTKB) is a Technology stock trading at $3.78 (as of 2026-06-18), with a market capitalization of $541.11M and a trailing P/E of -6.9. Figures are sourced from first-party U.S. SEC EDGAR filings and market data.

Cytek Biosciences provides cell analysis instruments, including full-spectrum fluorescence flow cytometers (Aurora and Northern Lights) and an Aurora cell sorter, along with consumables such as cFluor reagents and assay kits. It also offers automated sample-loading hardware and SpectroFlo software to support end-to-end workflows for research and clinical users analyzing single cells.

Valuation — source: SEC EDGAR (first-party)
Price	$3.78
Market Cap	$541.11M
P/E Ratio	-6.9
EV / EBITDA	-12.3
Price / Book	1.57
Price / Sales	2.52
DCF Value (model)	$-0.45
DCF Upside vs Price	-111.9%

Profitability & Growth — source: SEC EDGAR
Revenue (TTM)	$201.49M
Net Margin	-33.0%
Return on Equity	-22.6%
Current Ratio	4.69
Revenue Growth (YoY)	0.5%
FCF Growth (YoY)	-140.1%

Financial Health — source: SEC EDGAR
Altman Z-Score	3.09 (safe)

Valuation vs Sector & Industry
Stock P/E	-6.9
Sector P/E (Technology)	32.6
Industry P/E (Measuring & Control Equipment)	60.1
vs Sector	-121.0%
vs Industry	-111.4%

Smart-Money Activity — SEC Form 4 / 13F / Congressional disclosures
Top Institutional Holder	BlackRock, Inc. ($74.32M)
Institutional Holders Tracked	10

Company
Sector	Technology
Industry	Measuring & Control Equipment
CEO	Wenbin Jiang
Employees	663
Country	US
IPO Date	2021-07-23

Related Companies (Business model: Medical Devices / Life Science Tools; 8 closest by market cap; US-domiciled)

Data as of 2026-06-18.

Figures sourced from U.S. Securities and Exchange Commission (SEC EDGAR) filings and market data. Not personalized investment advice.